Romain Cohen, MD, PhD, Saint-Antoine Hospital, AP-HP, Paris, France, outlines the results of a meta-analysis of 12 adjuvant trials evaluating the efficacy of adjuvant fluoropyrimidine with or without oxaliplatin in patients with microsatellite instable (MSI) stage III colon cancer. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).